Submissions from 2022
Comparing abrocitinib and dupilumab in the treatment of atopic dermatitis: a plain language summary, Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg, Diamant Thaçi, Carle Paul, Andrew E. Pink, Yoko Kataoka, Chia-Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, and Hernan Valdez
Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3, Andrew Blauvelt, Melinda Gooderham, Neal Bhatia, Richard G. Langley, Shannon Schneider, John Zoidis, Azra Kurbasic, April Armstrong, and Jonathan I. Silverberg
Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis, Andrew Blauvelt, Leon Kircik, Kim A. Papp, Eric L. Simpson, Jonathan I. Silverberg, Brian S. Kim, Shawn G. Kwatra, Michael E. Kuligowski, May E. Venturanza, Shaoceng Wei, and Jacek C. Szepietowski
Itch-Free State in Patients With Atopic Dermatitis Treated With Ruxolitinib Cream: Pooled Analysis From Two Randomized Phase 3 Studies, Andrew Blauvelt, Jacek C. Szepietowski, Kim Papp, Eric L. Simpson, Jonathan I. Silverberg, Brian S. Kim, Shawn G. Kwatra, Michael E. Kuligowski, May E. Venturanza, Shaoceng Wei, and Leon Kircik
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies, Lisa Bloudek, Lawrence F. Eichenfield, Jonathan I. Silverberg, Vijay N. Joish, Jennifer H. Lofland, Kang Sun, Matthias Augustin, Kristen Migliaccio-Walle, and Sean D. Sullivan
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity, Otavio Cabral-Marques, Gilad Halpert, Lena F. Schimke, Yuri Ostrinski, Aristo Vojdani, Gabriela Crispim Baiocchi, Paula Paccielli Freire, Igor Salerno Filgueiras, Israel Zyskind, Miriam T. Lattin, Florian Tran, Stefan Schreiber, Alexandre H. Marques, Desirée Rodrigues Plaça, Dennyson Leandro Fonseca, Jens Y. Humrich, Antje Müller, Lasse M. Giil, Hanna Graßhoff, Anja Schumann, Alexander Hackel, Juliane Junker, Carlotta Meyer, Hans D. Ochs, Yael Bublil Lavi, Carmen Scheibenbogen, Ralf Dechend, Igor Jurisica, Kai Schulze-Forster, Jonathan I. Silverberg, Howard Amital, and Jason Zimmerman
Longitudinal course and predictors of depressive symptoms in atopic dermatitis, Sheena Chatrath, Donald Lei, Muhammad Yousaf, Rajeev Chavda, Sylvie Gabriel, and Jonathan I. Silverberg
Atopic Dermatitis Is Associated With Lower Patient Satisfaction in US Adults, Brian T. Cheng and Jonathan I. Silverberg
Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States, Raj Chovatiya, Wendy Smith Begolka, Isabelle J. Thibau, and Jonathan I. Silverberg
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States, Raj Chovatiya, Wendy Smith Begolka, Isabelle J. Thibau, and Jonathan I. Silverberg
DESCRIBE-AD: A novel classification framework for atopic dermatitis, Raj Chovatiya and Jonathan I. Silverberg
Evaluating the longitudinal course of atopic dermatitis: A review of the literature, Raj Chovatiya and Jonathan I. Silverberg
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice, Raj Chovatiya and Jonathan I. Silverberg
Iatrogenic Burden of Atopic Dermatitis, Raj Chovatiya and Jonathan I. Silverberg
Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries, Joel J. Credle, Jonathan Gunn, Puwanat Sangkhapreecha, Daniel R. Monaco, Xuwen Alice Zheng, Hung-Ji Tsai, Azaan Wilbon, William R. Morgenlander, Andre Rastegar, Yi Dong, Sahana Jayaraman, Lorenzo Tosi, Biju Parekkadan, Alan N. Baer, Mario Roederer, Evan M. Bloch, Aaron A. Tobian, Israel Zyskind, Jonathan I. Silverberg, Avi Z. Rosenberg, Andrea L. Cox, Tom Lloyd, Andrew L. Mammen, and H Benjamin Larman
AAD Guidelines: awareness of comorbidities associated with atopic dermatitis in adults, Dawn M. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Jonathan I. Silverberg, Anne Marie Singh, and Robert Sidbury
Sleep impairment in patients with chronic inflammatory skin diseases: A review of mechanisms and management, Grace Y. Duan and Jonathan I. Silverberg
An intertriginous eruption in an infant, Adaora Ewulu, Michael A. Cardis, and Kaiane A. Habeshian
1,550 nm Erbium-Doped and 1,927 nm Thulium Nonablative Fractional Laser System: Best Practices and Treatment Setting Recommendations, Paul M. Friedman, Jeffrey S. Dover, Anne Chapas, Zakia Rahman, Edward V. Ross, Suzanne L. Kilmer, Wendy E. Roberts, Pooja Sodha, Julie B. Stimmel, Mary Beth Moncrief, and Jill S. Waibel
Clinical features and eosinophilia in pityriasis rubra pilaris: A multicenter cohort, Shilpa Ghatnekar, Nidhi Shah, Michelle S. Min, Daniel R. Mazori, Avery H. LaChance, Ruth Ann Vleugels, and Vinod E. Nambudiri
Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial, Melinda J. Gooderham, Giampiero Girolomoni, Julian O. Moore, Jonathan I. Silverberg, Robert Bissonnette, Seth Forman, Elena Peeva, Pinaki Biswas, Hernan Valdez, and Gary Chan
Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial, Melinda J. Gooderham, Giampiero Girolomoni, Julian O. Moore, Jonathan I. Silverberg, Robert Bissonnette, Seth Forman, Elena Peeva, Pinaki Biswas, Hernan Valdez, and Gary Chan
Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes, Lawrence J. Green, Edward Lain, Thomas Prunty, and Robert Rhoades
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo B. Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Howard L. Kaufman, Frank Seebach, Israel Lowy, Suk-Young Yoo, Melissa Mathias, Keilah Fenech, Hyunsil Han, Matthew G. Fury, and Danny Rischin
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo B. Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Howard L. Kaufman, Frank Seebach, Israel Lowy, Suk-Young Yoo, Melissa Mathias, Keilah Fenech, Hyunsil Han, Matthew G. Fury, and Danny Rischin
Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study, Sigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L. Ámundadóttir, Judit Mészáros, Jenna H. Eysteinsdóttir, Ragna H. Thorleifsdóttir, Sigrídur K. Hrafnkelsdóttir, Heida B. Bragadóttir, Saemundur Oddsson, and Jonathan I. Silverberg
Clinical Efficacy of a Digital Intervention for Patients with Atopic Dermatitis: a Prospective Single-Center Study, Sigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L. Ámundadóttir, Judit Mészáros, Jenna H. Eysteinsdóttir, Ragna H. Thorleifsdóttir, Sigrídur K. Hrafnkelsdóttir, Heida B. Bragadóttir, Saemundur Oddsson, and Jonathan I. Silverberg
Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies, Emma Guttman-Yassky, Jacob P. Thyssen, Jonathan I. Silverberg, Kim A. Papp, Amy S. Paller, Stephan Weidinger, H Chih-Ho Hong, Barbara Hendrickson, Deanne Dilley, Allan R. Tenorio, Barry Ladizinski, Alvina D. Chu, John Liu, and Alan D. Irvine
Psychological Interventions Are More Effective Than Educational Interventions at Improving Atopic Dermatitis Severity: A Systematic Review, Tammy Hua, Lori S. Kim, Muhammad Yousaf, Eran C. Gwillim, Yik W. Yew, Brad Lee, Kevin Hua, Taylor Erickson, Brian Cheng, Kevin Patel, and Jonathan Ian Silverberg
Assessment of the validity of international classification of disease tenth revision codes for atopic dermatitis, Sneha Iyer, Nisha Patel, Eric Sanfilippo, Robert P. Dellavalle, and Jonathan I. Silverberg
Tropical parasitic itch in returned travellers and immigrants from endemic areas, T Ju, A Vander Does, G Ingrasci, S A. Norton, and G Yosipovitch
Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review, Trisha Kaundinya, Uros Rakita, Armaan Guraya, Donna Maria Abboud, Emily Croce, Jacob P. Thyssen, Andrew Alexis, and Jonathan I. Silverberg
Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patients, Jonette Keri, Fran E. Cook-Bolden, Lawrence Green, Leon H. Kircik, Hilary Baldwin, William Philip Werschler, Eric Guenin, Radhakrishnan Pillai, and Varsha Bhatt
Feeling the burn: Sunburn recall in staphylococcal scalded skin syndrome, Rayva Khanna, Emily L. Guo, and Anna Yasmine Kirkorian
Dermal sensitization, safety, tolerability, and patient preference of tazarotene 0.045% lotion from five clinical trials, Leon H. Kircik, Lawrence Green, Eric Guenin, Waleed Khalid, and Binu Alexander
Combination 1550 nm non-ablative fractional resurfacing and laser hair removal for treatment of Becker's nevi in skin types III-VI, Shelby L. Kubicki, Emily L. Guo, Pooja Sodha, Heather Richmond, and Paul M. Friedman
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials, Mark G. Lebwohl, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Zoe D. Draelos, Melinda J. Gooderham, Kim A. Papp, Jerry Bagel, Neal Bhatia, James Q. Del Rosso, Laura K. Ferris, Lawrence J. Green, Adelaide A. Hebert, Terry Jones, Steven E. Kempers, David M. Pariser, Paul S. Yamauchi, Matthew Zirwas, Lorne Albrecht, Alim R. Devani, Mark Lomaga, Amy Feng, Scott Snyder, Patrick Burnett, Robert C. Higham, and David R. Berk
Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis, Mark G. Lebwohl, Linda Stein Gold, James Q. Del Rosso, Lawrence Green, and Abby Jacobson
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years, Thomas A. Luger, Adelaide A. Hebert, Andrea L. Zaenglein, Jonathan I. Silverberg, Huaming Tan, William C. Ports, and Michael A. Zielinski
Longitudinal Course of Sleep Disturbance and Relationship With Itch in Adult Atopic Dermatitis in Clinical Practice, Jaya Manjunath, Donald Lei, Adnan Ahmed, Marissa Ayasse, Rajeev Chavda, Sylvie Gabriel, and Jonathan Ian Silverberg
Association of obesity in early childhood with atopic dermatitis in late childhood and adolescence, Jaya Manjunath and Jonathan I. Silverberg
A dialysis patient with subungual hyperkeratosis and ulceration of the fingertips, Sarah H. Millan, Karl M. Saardi, Ardeshir Edward Nadimi, and Scott A. Norton
Racial disparities in dermatology, Shanthi Narla, Candrice R. Heath, Andrew Alexis, and Jonathan I. Silverberg
The suitability of treating atopic dermatitis with Janus kinase inhibitors, Shanthi Narla and Jonathan I. Silverberg
Practices and perspectives on medical cannabis and cannabinoids: A survey of the National Psoriasis Foundation Medical Advisory Board, Dillon Nussbaum, Sapana Desai, Adrianna Gonzalez-Lopez, Jason E. Hawkes, George Gondo, and Adam Friedman
Reduction in new pityriasis rosea diagnoses during the COVID-19 pandemic: Evidence in support of a viral etiology, Dillon Nussbaum, Chapman Wei, Haig Pakhchanian, Rahul Raiker, Ivan Z. Liu, and Adam Friedman
Reply to "Pityriasis rosea during COVID-19 and its pathogenesis", Dillon Nussbaum, Chapman Wei, Haig Pakhchanian, Rahul Raiker, Ivan Z. Liu, and Adam Friedman
Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis, Paul Oykhman, Jared Dookie, Husam Al-Rammahy, Anna de Benedetto, Rachel N. Asiniwasis, Jennifer LeBovidge, Julie Wang, Peck Y. Ong, Peter Lio, Alvin Gutierrez, Korey Capozza, Stephen A. Martin, Winfred Frazier, Kathryn Wheeler, Mark Boguniewicz, Jonathan M. Spergel, Matthew Greenhawt, Jonathan I. Silverberg, Lynda Schneider, and Derek K. Chu
The utility of laboratory testing for pediatric patients undergoing isotretinoin treatment, Varsha Parthasarathy, Nidhi Shah, and Anna Yasmine Kirkorian
Cutaneous squamous cell carcinoma staging may influence management in users: A survey study., Vishal A. Patel, Catherine McCullum, Andrew D. Sparks, Chrysalyne D Schmults, Sarah T Arron, and Anokhi Jambusaria-Pahlajani
A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis, A Pinter, L J. Green, J Selmer, M Praestegaard, L S. Gold, and M Augustin
Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitis, J Puelles, F Fofana, D Rodriguez, J I. Silverberg, A Wollenberg, C Dias Barbosa, M Vernon, R Chavda, S Gabriel, and C Piketty
Association of atopic dermatitis severity with menstrual worsening of disease in women: a cross-sectional study., U Rakita, T Kaundinya, and J I. Silverberg
Associations between onychomycosis and COVID-19 clinical outcomes: a retrospective cohort study from a US metropolitan center, Uros Rakita, Trisha Kaundinya, Armaan Guraya, Kamaria Nelson, Brittany Maner, Jaya Manjunath, Gabrielle Schwartzman, Brittany Lane, and Jonathan I. Silverberg
Differences between pediatric and adult atopic dermatitis, Hassiel A. Ramírez-Marín and Jonathan I. Silverberg
Food allergy testing in atopic dermatitis, Hassiel A. Ramírez-Marín, Anne Marie Singh, Peck Y. Ong, and Jonathan I. Silverberg
Prevalence and associations of fatigue in childhood atopic dermatitis: a cross-sectional study, Stephanie M. Rangel, Theodore Kim, Anjani Sheth, Alli Blumstein, Jin-Shei Lai, David Cella, Amy S. Paller, and Jonathan I. Silverberg
Numerous Angiomatous Lesions in an Infant, Catherine Reilly, Nidhi Shah, and Kaiane Habeshian
Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysis, Alex M. Rokni, Marissa Ayasse, Adnan Ahmed, Lauren Guggina, Robert W. Kantor, and Jonathan I. Silverberg
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study, Maria C. Schneeweiss, Julien Kirchgesner, Richard Wyss, Yinzhu Jin, Cassandra York, Joseph F. Merola, Arash Mostaghimi, Jonathan I. Silverberg, Sebastian Schneeweiss, and Robert J. Glynn
Venous Thromboembolism in Chronic Inflammatory Skin Diseases-The Need to Consider Bullous Pemphigoid-Reply, Maria C. Schneeweiss, Jonathan I. Silverberg, and Arash Mostaghimi
Incidence of Bacterial and Nonbacterial Conjunctivitis in Patients With Atopic Dermatitis Treated With Dupilumab: A US Multidatabase Cohort Study, Maria C. Schneeweiss, Richard Wyss, Kristyn Chin, Joseph F. Merola, Jonathan I. Silverberg, Arash Mostaghimi, and Sebastian Schneeweiss
Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications, Gabrielle H. Schwartzman, Paige K. Dekker, Anna S. Silverstein, Natalia M. Fontecilla, and Scott A. Norton
Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications, Gabrielle H. Schwartzman, Paige K. Dekker, Anna S. Silverstein, Natalia M. Fontecilla, and Scott A. Norton
Association of Adult Atopic Dermatitis Severity With Decreased Physical Activity: A Cross-sectional Study, Gabrielle Schwartzman, Donald Lei, Adnan Ahmed, Rajeev Chavda, Sylvie Gabriel, and Jonathan I. Silverberg
Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis, G Schwartzman, D Lei, A Ahmed, R Chavda, S Gabriel, and J I. Silverberg
Patient perspectives of atopic dermatitis: comparative analysis of terminology in social media and scientific literature, identified by a systematic literature review, J I. Silverberg, S R. Feldman, W Smith Begolka, M B. Johnson, C Stanojev, M DiBonaventura, R Rojo Cella, H Valdez, C Feeney, and J P. Thyssen
Pharmacology of orismilast, a potent and selective PDE4 inhibitor, J I. Silverberg, L E. French, R B. Warren, B Strober, K Kjøller, M O. Sommer, P Andres, J Felding, A Weiss, D Tutkunkardas, Tine Skak-Nielsen, and E Guttman
Long-Term Efficacy (up to 68 Weeks) of Baricitinib in Combination with Topical Corticosteroids in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Analysis of Treatment Responders, Partial Responders and Nonresponders Originating from Study BREEZE-AD7, J I. Silverberg, E L. Simpson, J P. Thyssen, T Werfel, T Cardillo, S Colvin, E Pierce, Y Chen, S Chen, and L Eichenfield
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis, Jonathan I. Silverberg, David N. Adam, Matthew Zirwas, Sunil Kalia, Jan Gutermuth, Andreas Pinter, Andrew E. Pink, Andrea Chiricozzi, Sebastien Barbarot, Thomas Mark, Ann-Marie Tindberg, and Stephan Weidinger
Epidemiology and Burden of Sleep Disturbances in Atopic Dermatitis in US Adults, Jonathan Ian Silverberg, Zelma Chiesa-Fuxench, David Margolis, Mark Boguniewicz, Luz Fonacier, Mitchell Grayson, Eric Simpson, and Peck Ong
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials, Jonathan I. Silverberg, Mark Boguniewicz, Jon Hanifin, Kim A. Papp, Haixin Zhang, Ana B. Rossi, and Noah A. Levit
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials, Jonathan I. Silverberg, Mark Boguniewicz, Jon Hanifin, Kim A. Papp, Haixin Zhang, Ana B. Rossi, and Noah A. Levit
Clinical Tailoring of Baricitinib 2 mg in Atopic Dermatitis: Baseline Body Surface Area and Rapid Onset of Action Identifies Response at Week 16, Jonathan I. Silverberg, Mark Boguniewicz, Jill Waibel, Jamie Weisman, Lindsay Strowd, Luna Sun, Yuxin Ding, Meghan Feely, Fabio P. Nunes, and Eric L. Simpson
Upadacitinib plus topical corticosteroids in atopic dermatitis: Week 52 AD Up study results, Jonathan I. Silverberg, Marjolein de Bruin-Weller, Thomas Bieber, Weily Soong, Kenji Kabashima, Antonio Costanzo, David Rosmarin, Charles Lynde, John Liu, Amy Gamelli, Jiewei Zeng, Barry Ladizinski, Alvina D. Chu, and Kristian Reich
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis, Jonathan I. Silverberg, H Chih-Ho Hong, Jacob P. Thyssen, Brian M. Calimlim, Avani Joshi, Henrique D. Teixeira, Eric B. Collins, Marjorie M. Crowell, Scott J. Johnson, and April W. Armstrong
Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis, Jonathan I. Silverberg, H Chih-Ho Hong, Jacob P. Thyssen, Brian M. Calimlim, Avani Joshi, Henrique D. Teixeira, Eric B. Collins, Marjorie M. Crowell, Scott J. Johnson, and April W. Armstrong
Allergens in patients with a diagnosis of seborrheic dermatitis, North American Contact Dermatitis Group data, 2001-2016, Jonathan I. Silverberg, Alexander Hou, Erin M. Warshaw, Howard I. Maibach, Donald V. Belsito, Joel G. DeKoven, Kathryn A. Zug, James S. Taylor, Denis Sasseville, Anthony F. Fransway, Vincent A. DeLeo, Melanie D. Pratt, Margo J. Reeder, Amber R. Atwater, Joseph F. Fowler, Matthew J. Zirwas, James G. Marks, Cory A. Dunnick, and Marie-Claude Houle
Lanolin Allergic Reactions: North American Contact Dermatitis Group Experience, 2001 to 2018, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Donald V. Belsito, Cory A. Dunnick, Marie-Claude Houle, Margo J. Reeder, Howard I. Maibach, Kathryn A. Zug, James S. Taylor, Denis Sasseville, Anthony F. Fransway, Vincent A. DeLeo, Melanie D. Pratt, Joseph F. Fowler, and Matthew J. Zirwas
Lanolin Allergic Reactions: North American Contact Dermatitis Group Experience, 2001 to 2018, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Donald V. Belsito, Cory A. Dunnick, Marie-Claude Houle, Margo J. Reeder, Howard I. Maibach, Kathryn A. Zug, James S. Taylor, Denis Sasseville, Anthony F. Fransway, Vincent A. DeLeo, Melanie D. Pratt, Joseph F. Fowler, and Matthew J. Zirwas
Patch testing with cobalt in children and adolescents: North American contact dermatitis group experience, 2001-2018, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Howard I. Maibach, Donald V. Belsito, Joel G. DeKoven, Kathryn A. Zug, James S. Taylor, Denis Sasseville, Vincent A. DeLeo, Melanie D. Pratt, Margo J. Reeder, Amber R. Atwater, Joseph F. Fowler, and Marie-Claude Houle
Single-question parent-reported global atopic dermatitis severity: A valid instrument in children, Jonathan I. Silverberg, Stephanie M. Rangel, Anjani Sheth, Alli Blumstein, and Amy S. Paller
Dupilumab Treatment Reduces Hospitalizations in Adults with Moderate-to-Severe Atopic Dermatitis, Jonathan I. Silverberg, Norma P. Rubini, Mario C. Pires, Ana B. Rossi, Annie Zhang, Zhen Chen, Noah A. Levit, Jingdong Chao, Brad Shumel, and Gaëlle Bégo-Le Bagousse
Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS), Jonathan I. Silverberg, Eric L. Simpson, Brian M. Calimlim, Leighann Litcher-Kelly, Xiaoran Li, Xiaowu Sun, and Yael A. Leshem
Determining Severity Strata for Three Atopic Dermatitis Patient-Reported Outcome Questionnaires: Defining Severity Score Ranges for the Worst Pruritus Numerical Rating Scale and the Atopic Dermatitis Symptom and Impact Scales (ADerm-SS and ADerm-IS), Jonathan I. Silverberg, Eric L. Simpson, Brian M. Calimlim, Leighann Litcher-Kelly, Xiaoran Li, Xiaowu Sun, and Yael A. Leshem
Predictors of chronic COVID-19 symptoms in a community-based cohort of adults, Jonathan I. Silverberg, Israel Zyskind, Hiam Naiditch, Jason Zimmerman, Aaron E. Glatt, Abraham Pinter, Elitza S. Theel, Michael J. Joyner, D Ashley Hill, Miriam R. Lieberman, Elliot Bigajer, Daniel Stok, Elliot Frank, and Avi Z. Rosenberg
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes, Eric Simpson, April Armstrong, Mark Boguniewicz, Zelma C. Chiesa Fuxench, Meghan Feely, Evangeline Pierce, Luna Sun, Yun-Fei Chen, Robinette Angle, and Jonathan I. Silverberg
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes, Eric Simpson, April Armstrong, Mark Boguniewicz, Zelma C. Chiesa Fuxench, Meghan Feely, Evangeline Pierce, Luna Sun, Yun-Fei Chen, Robinette Angle, and Jonathan I. Silverberg
Safety of Tralokinumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-blind, Placebo-controlled Phase 2 and Phase 3 Trials, Eric L. Simpson, Joseph F. Merola, Jonathan I. Silverberg, Kristian Reich, Richard B. Warren, Delphine Staumont-Sallé, Giampiero Girolomoni, Kim Papp, Marjolein de Bruin-Weller, Jacob P. Thyssen, Rebecca Zachariae, Christiana K. Olsen, and Andreas Wollenberg
Patient-oriented measures for phase 3 studies of tralokinumab for treatment of atopic dermatitis (ECZTRA 1, 2 and 3), Eric L. Simpson, Andreas Wollenberg, Weily Soong, Louise Abildgaard Steffensen, Azra Kurbasic, Shannon Schneider, John Zoidis, and Jonathan I. Silverberg
Olfactory dysfunction in children and adults post-COVID-19 infection in Brooklyn, New York, Tamar A. Smith-Norowitz, Jonathan I. Silverberg, Esther M. Norowitz, Jeffrey Loeffler, Margaret R. Hammerschlag, and Stephan Kohlhoff
Acoustic Shockwave Therapy as an Adjunct to Picosecond Laser for Multicolored Tattoo Removal, Pooja Sodha, Jordan V. Wang, and Paul M. Friedman
High threshold efficacy responses in moderate-to-severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studies in adults and adolescents, S Ständer, N Bhatia, M J. Gooderham, J I. Silverberg, J P. Thyssen, P Biswas, M DiBonaventura, W Romero, and S A. Farooqui
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial, Sonja Ständer, Shawn G. Kwatra, Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Gil Yosipovitch, Fan Zhang, Michael C. Cameron, Ricardo Rojo Cella, Hernan Valdez, Marco DiBonaventura, and Claire Feeney
Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial, Linda Stein Gold, Kim Papp, David Pariser, Lawrence Green, Neal Bhatia, Howard Sofen, Lorne Albrecht, Melinda Gooderham, Mindy Chen, Maria Paris, Yao Wang, and Kristina Callis Duffin
Improving dermatology residency program website transparency in the era of preference signaling., Surya A Veerabagu, Justin Jia, Zizi Yu, David Gao, Jared S Kahn, Jordan Tanner, Nicole M Burkemper, Adam J. Friedman, Jennifer T Huang, Kristin M Nord, David Rosmarin, and Andrea T Murina
The National Mentorship Match Algorithm: A new approach to filling mentorship gaps, Surya A. Veerabagu, Rebecca Trinklein, Jeremy R. Etzkorn, Thomas H. Leung, Christopher J. Miller, Ilana S. Rosman, and Adam J. Friedman
Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets, R B. Warren, B Strober, J I. Silverberg, E Guttman, P Andres, J Felding, D Tutkunkardas, K Kjøller, M O. Sommer, and L E. French
Occupational Contact Dermatitis in Dental Personnel: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001 to 2018, Erin M. Warshaw, Jenna L. Ruggiero, Amber R. Atwater, Joel G. DeKoven, Kathryn A. Zug, Margo J. Reeder, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Howard I. Maibach, Marie-Claude Houle, Donald V. Belsito, Joseph F. Fowler, Cory A. Dunnick, Vincent A. DeLeo, Denis Sasseville, and Anthony F. Fransway
Patch Test Reactions Associated With Topical Medications: A Retrospective Analysis of the North American Contact Dermatitis Group Data (2001-2018), Erin M. Warshaw, Rob L. Shaver, Joel G. DeKoven, James S. Taylor, Amber R. Atwater, Anthony F. Fransway, Howard I. Maibach, Donald V. Belsito, Jonathan I. Silverberg, Marie-Claude Houle, Margo J. Reeder, Kathryn A. Zug, Joseph F. Fowler, Denis Sasseville, Melanie D. Pratt, Cory A. Dunnick, and Vincent A. DeLeo